Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-18

Clinical Trial Update: A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy [Phase 4]

View source ↗

Summary

A randomized double-blind Phase 4 trial studied pregabalin for diabetic neuropathy. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Duke University | Conditions: Diabetic Neuropathy | Phase 4 | Status: COMPLETED | Results posted: 2013-07-18